Feasibility study on the clinical translation of a remote jaundice monitoring system for home-based screening of neonatal hyperbilirubinemia.
10.7499/j.issn.1008-8830.2503110
- Author:
Xiao-Fan SUN
1
;
Yi ZHENG
1
;
Ai-Ling SU
1
;
Shu-Ping HAN
1
;
Xiao-Yue DONG
1
Author Information
1. Department of Pediatrics, Women's Hospital of Nanjing Medical University/Nanjing Women and Children's Healthcare Hospital, Nanjing 210004, China.
- Publication Type:Journal Article
- Keywords:
Home screening;
Neonatal hyperbilirubinemia;
Newborn;
Transcutaneous bilirubin
- MeSH:
Humans;
Infant, Newborn;
Female;
Male;
Bilirubin/blood*;
Feasibility Studies;
Prospective Studies;
Hyperbilirubinemia, Neonatal/diagnosis*;
Neonatal Screening/methods*;
Jaundice, Neonatal/diagnosis*
- From:
Chinese Journal of Contemporary Pediatrics
2025;27(9):1057-1061
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To evaluate the clinical utility and translational potential of a remote jaundice monitoring system for home-based screening of neonatal hyperbilirubinemia.
METHODS:A prospective self-controlled study was conducted, enrolling 538 newborns with gestational age ≥35 weeks, birth weight ≥2 000 g, and postnatal age ≤14 days at the Women's Hospital of Nanjing Medical University from March to October 2023. Four screening protocols with different predictive indicators were developed based on the Chinese Neonatal Transcutaneous Hourly Bilirubin Nomogram. The effectiveness of the system was evaluated, and the feasibility of using the remote jaundice monitoring system in actual home settings was analyzed.
RESULTS:A total of 538 paired transcutaneous bilirubin (TcB) and total serum bilirubin (TSB) measurements showed a strong correlation (r=0.85, P<0.001), with 95.0% (511/538) of samples within the 95% limits of agreement. Using TcB ≥ the 95th percentile as the predictive indicator, the system achieved 100% sensitivity, 46.2% specificity, and an area under the receiver operating characteristic curve of 0.731 (95%CI: 0.682-0.780). This approach could reduce unnecessary hospital visits by 41.4% (221/538).
CONCLUSIONS:The system integrates the QBH-801 transcutaneous bilirubinometer, intelligent early warning, and remote guidance services, establishing a closed-loop "hospital-to-home" management model. It demonstrates high safety and feasibility, with significant clinical translational value.
